UK (UC)_ The Covid-19 pandemic at start of 2020 and more recently monkeypox have drawn attention once again to the significance of biotechnology in the development of new vaccines and caution in regards to their safety as well as the need for novel drugs that can be administered via the nasal passage believed to be more effective in fending off the infection at the source.
Constructive Bio a biotechnology firm-based in the UK, has secured a seed initial investment of…